diagnostics

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital HeidelbergInvestment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

TOKYO, April 23, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 679 million…

1 day ago
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross ProceedsBluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

April 07, 2025 17:21 ET  | Source: Bluejay Diagnostics, Inc. ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…

2 weeks ago
OMNICOM MEDIA GROUP AGENCY OMD TAKES TOP SLOT IN RECMA DIAGNOSTICS REPORT FOR NINTH CONSECUTIVE EDITION, REINFORCING ITS LEAD IN THE MARKETPLACEOMNICOM MEDIA GROUP AGENCY OMD TAKES TOP SLOT IN RECMA DIAGNOSTICS REPORT FOR NINTH CONSECUTIVE EDITION, REINFORCING ITS LEAD IN THE MARKETPLACE

OMNICOM MEDIA GROUP AGENCY OMD TAKES TOP SLOT IN RECMA DIAGNOSTICS REPORT FOR NINTH CONSECUTIVE EDITION, REINFORCING ITS LEAD IN THE MARKETPLACE

NEW YORK, March 20, 2025 /PRNewswire/ -- In the latest edition of the Network Diagnostics report from RECMA (Research Company Evaluating the…

1 month ago
Pearl Partners with Medit to Enhance AI-Powered Dental Diagnostics in Intraoral Scanning and Medit Link Software PlatformPearl Partners with Medit to Enhance AI-Powered Dental Diagnostics in Intraoral Scanning and Medit Link Software Platform

Pearl Partners with Medit to Enhance AI-Powered Dental Diagnostics in Intraoral Scanning and Medit Link Software Platform

By integrating Pearl's AI-powered diagnostic solutions with Medit Link, dental clinicians will gain access to advanced diagnostic support and enhanced communication…

1 month ago
Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological LaboratoriesTotal Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories

Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories

TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.7…

1 month ago
A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and OthersA Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and Others

A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and Others

TOKYO, Jan. 30, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2…

3 months ago
CrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in BengaluruCrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in Bengaluru

CrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in Bengaluru

BENGALURU, India, Jan. 16, 2025 /PRNewswire/ -- Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and…

3 months ago
CrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in BengaluruCrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in Bengaluru

CrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in Bengaluru

BENGALURU, India, Jan. 16, 2025 /PRNewswire/ -- Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and…

3 months ago
Effective 02/07/2025, Interpace Diagnostics to No Longer Offer PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer RiskEffective 02/07/2025, Interpace Diagnostics to No Longer Offer PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

Effective 02/07/2025, Interpace Diagnostics to No Longer Offer PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

PARSIPPANY, NJ, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX:…

3 months ago
Roche transforms mass spectrometry diagnostics with launch of cobas Mass Spec solutionRoche transforms mass spectrometry diagnostics with launch of cobas Mass Spec solution

Roche transforms mass spectrometry diagnostics with launch of cobas Mass Spec solution

December 18, 2024 01:00 ET  | Source: F. Hoffmann-La Roche Ltd Roche launches its cobas® Mass Spec solution, bringing mass…

4 months ago
Show more Posts